The Scientific World Journal

The Scientific World Journal / 2002 / Article

Mini-Review Article | Open Access

Volume 2 |Article ID 287124 | 6 pages | https://doi.org/10.1100/tsw.2002.163

Cell Death and Ageing – A Question of Cell Type

Received19 Dec 2001
Revised06 Feb 2002
Accepted11 Feb 2002

Abstract

Replicative senescence of human cells in primary culture is a widely accepted model for studying the molecular mechanisms of human ageing. The standard model used for studying human ageing consists of fibroblasts explanted from the skin and grown into in vitro senescence. From this model, we have learned much about molecular mechanisms underlying the human ageing process; however, the model presents clear limitations. In particular, a long-standing dogma holds that replicative senescence involves resistance to apoptosis, a belief that has led to considerable confusion concerning the role of apoptosis during human ageing. While there are data suggesting that apoptotic cell death plays a key role for ageing in vitro and in the pathogenesis of various age-associated diseases, this is not reflected in the current literature on in vitro senescence. In this article, I summarize key findings concerning the relationship between apoptosis and ageing in vivo and also review the literature concerning the role of apoptosis during in vitro senescence. Recent experimental findings, summarized in this article, suggest that apoptotic cell death (and probably other forms of cell death) are important features of the ageing process that can also be recapitulated in tissue culture systems to some extent. Another important lesson to learn from these studies is that mechanisms of in vivo senescence differ considerably between various histotypes.


More related articles

64 Views | 367 Downloads | 3 Citations
 PDF  Download Citation  Citation
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.